1.
Manar G. Helal. Empagliflozin attenuates cyclophosphamide-induced hepatotoxicity via targeting Nrf2/HO-1 signaling, oxidative stress, and inflammation. World J Pharm Sci [Internet]. 2019 Nov. 5 [cited 2025 Jun. 27];7(11):49-5. Available from: https://www.wjpsonline.com/index.php/wjps/article/view/empagliflozin-attenuates-cyclophosphamide-induced-hepatotoxicity